Triple-negative breast cancer (TNBC) is characterized by estrogen receptor-, progesterone receptor-, and HER2-negative, which is extremely aggressive with a high risk of metastasis60,61. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.